Western Drug Recalls Marcaine Injection Due to Sterility Concerns
Western Drug Inc. is recalling 5 containers of Marcaine 0.24%/Ethanol 4% Injection because the product lacks assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls involving significant injury/property-damage reports or structural defects are Severe; while no injuries are reported here, the 'Lack of Assurance of Sterility' for an injectable drug represents a significant risk of harm (infection) that aligns with the Severe tier for high-risk products where injury has not yet been reported but the hazard is serious.
Plain-English summary
Western Drug Inc. is recalling 5 containers of Marcaine 0.24%/Ethanol 4% Injection. The recall is being conducted because the product lacks assurance of sterility. The affected product is a prescription medication manufactured by Western Drug Inc. located in Springerville, Arizona.
The recall covers all lots of the product. Distribution was nationwide in the United States, specifically in Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah. The agency has classified this recall as Class II.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions. The source text does not report any specific illnesses or injuries associated with this recall.
The recalled product
- Product
- Marcaine 0.24%/Ethanol 4% Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938
- Manufacturer
- Western Drug
- Category
- Drug — Injectable Anesthetic
- Affected units
- 5
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Part of a larger recall action
This product is one of 91 recalled by Western Drug under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 91 products in this recall →Related recalls
Same manufacturer · Western Drug
See all →- SevereWestern Drug Recalls Sodium Hydroxide 10% Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Benadryl Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls PZI 40 Insulin Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Ketorolac Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
Same hazard · sterility
See all →- SevereHouston Rx LLC Recalls Tirzepatide/Niacinamide Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-21
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereGreen Valley Drugs Recalls Methylprednisolone and Marcaine Injections for Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Alprostadil/Procaine Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Injectable Solution Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereMeditech Formula 4 Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2016-04-13
- HighInjectable drug product recalled due to sterility assurance failure
FDA (Drugs) · 2023-02-01
- SevereRXQ Compounding Recalls Diazepam Injection Due to Sterility Concerns
FDA (Drugs) · 2019-08-14